Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes
about
Schizophrenia and autism as contrasting minds: neural evidence for the hypo-hyper-intentionality hypothesisSynergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma.Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.Apoptosis and molecular targeting therapy in cancer.The Elephant in the Room: The Role of Microtubules in Cancer.Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways.Role of tumor necrosis factor alpha-induced protein 1 in paclitaxel resistance.Tumor shrinkage and improved quality of life in a heavily pretreated metastatic breast cancer patient treated with eribulin.Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.Comparative analyses of the β-tubulin gene and molecular modeling reveal molecular insight into the colchicine resistance in kinetoplastids organisms.Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma.Structural thermal adaptation of β-tubulins from the Antarctic psychrophilic protozoan Euplotes focardii
P2860
Q27320000-7A14E5EB-8138-40D0-99BD-F946AD8488C9Q35167498-4AAE4AA3-E045-4ADC-85D5-3F1F75A51EFDQ35988876-12890F86-FDFF-467D-BB9C-3EEAE325EFAEQ37482728-73AD8B1F-5DF7-4839-920E-44A6A1DF7925Q38060185-A74A1CCF-0028-4B92-ADF7-A1D7AB851462Q38228349-F19613BE-D1CE-4CBB-9492-089A13AB5011Q38672574-5BF2603C-A9ED-4456-9066-C4E8FC8C6278Q39095950-E581A1F6-8FB0-4E7F-8566-43A291663A84Q39115898-0396919C-1DAF-4C92-9718-B6CA82BFEF39Q39326914-51F72F25-4BC5-4772-88CD-3FC6F593EF6EQ39336478-0FD7CF80-4124-49F1-B261-2322B4A57BACQ42971520-526CE017-AFA3-4A12-AFE7-61722056504BQ44700184-01046EAE-C25D-4025-BCF6-4F801F53F94EQ56927698-F6ED0E30-5F70-46DD-86AC-D1453A6561C8
P2860
Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@ast
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@en
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@nl
type
label
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@ast
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@en
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@nl
prefLabel
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@ast
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@en
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@nl
P2093
P2860
P3181
P1433
P1476
Cancer cells acquire mitotic d ...... ssion of beta-tubulin isotypes
@en
P2093
Chi-Yen Chang
Chun Hei Antonio Cheung
Hsing-Pang Hsieh
Jang-Yang Chang
Jian-Sung Wu
Su-Ying Wu
Tian-Ren Lee
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0012564
P407
P577
2010-09-03T00:00:00Z